• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

22.58 -0.47 (-2.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
Earnings Preview: Apellis Pharmaceuticals ↗
May 03, 2023
 
Via Benzinga
News headline image
Apellis Pharmaceuticals to Present at the Bank of America Securities 2023 Healthcare Conference
May 03, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today ↗
May 01, 2023
These three biotech stocks were on the volatile side today. 
Via The Motley Fool
News headline image
Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma ↗
May 01, 2023
The company is working on a treatment for the eye disease known as geographic atrophy. 
Via Investor's Business Daily
News headline image
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗
April 27, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Wedbush Maintains Neutral Rating for Apellis Pharmaceuticals: Here's What You Need To Know ↗
April 17, 2023
 
Via Benzinga
News headline image
9 Analysts Have This to Say About Apellis Pharmaceuticals ↗
April 14, 2023
 
Via Benzinga
News headline image
Why Apellis Pharmaceuticals Stock Is Soaring Today ↗
April 03, 2023
Rare disease-focused Apellis Pharmaceuticals Inc (NASDAQ: APLS) is reportedly drawing takeover interest from large drugmakers. 
Via Benzinga
News headline image
Apellis Pharmaceuticals to Host Conference Call on May 4, 2023, to Discuss First Quarter 2023 Financial Results
April 27, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
April 26, 2023
 
Via Benzinga
News headline image
Apellis Presents Phase 3 Functional Analyses of SYFOVRE™ (pegcetacoplan injection) for Geographic Atrophy
April 23, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
2 Best Growth Stocks to Buy in April ↗
April 03, 2023
Takeover interest is spurring these two biotech stocks higher. 
Via The Motley Fool
News headline image
Apellis Pharmaceuticals's Return On Capital Employed Insights ↗
February 22, 2023
 
Via Benzinga
News headline image
Apellis Announces Validation of Four Marketing Applications for Pegcetacoplan for Geographic Atrophy
April 21, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
April 19, 2023
 
Via Benzinga
News headline image
Apellis Partners with Acclaimed Actor Henry Winkler to Raise Awareness of Geographic Atrophy (GA) for the GA Won’t Wait™ Campaign
April 17, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
April 12, 2023
 
Via Benzinga
News headline image
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 06, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
April 03, 2023
 
Via Benzinga
Apellis Pharmaceuticals Inc. (NASDAQ: APLS) Making Surprising Moves in Monday Session
April 03, 2023
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
April 03, 2023
 
Via Benzinga
News headline image
Apellis Pharmaceuticals, VirTra And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
April 03, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
March 01, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Option to Purchase Additional Shares
February 27, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Wall Street Upgraded This Stock's Price Target After a New Approval: Is It a Buy? ↗
February 27, 2023
The company's lead therapy was just approved for another indication. 
Via The Motley Fool
News headline image
Why Apellis Pharmaceuticals Stock Surged This Week ↗
February 24, 2023
A highly eventful five days for the company saw bulls pile into its shares. 
Via The Motley Fool
News headline image
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
February 22, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
February 22, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap